 |
“How
wonderful it is that you can actually cure not only local disease
but also maybe change the state of mind, the attitude to life, and
bring that patient back to being normal again. You have a wonderful
technology to sell to physicians and, in particular, to patients.”

|
|

| Professor Eberhard Grube, M.D., TAXUS
I Clinical Trial Principal Investigator and Chief of Cardiology/Angiology
at the Heart Center Siegburg, Germany. |
|
 |
 |